Quality culture in the pharmaceutical industry: the real diagnosis (spoiler: it’s not a poster)
A charter displayed at the workshop entrance, a successful audit, a Quality week: all of this feels good, but says nothing about a site’s quality culture. It can’t be read on the walls. It shows in what people do when nobody is watching.
What quality culture really is
Quality culture is the set of convictions, values and reflexes shared by the members of an organisation, with one goal: a product that is compliant, safe and effective. It determines how everyone reacts to an unexpected situation.
It often plays out in the small shortcuts of everyday work: going back for your laptop on the other side of the airlock after taking off your overshoes, not removing a guard during line clearance because “there’s never anything behind it”, not reporting something odd because you’re already running late. These shortcuts aren’t ill will: they stem from habit, pressure, fatigue and, above all, a lack of understanding of the risks.
The four maturity levels
A site’s quality culture sits on a four-level curve. The higher you go, the fewer quality incidents there are: deviations, out-of-specification results, complaints, batch recalls.
- Endure. Problems only get attention once they have happened. Quality is the business of the Quality department alone, and management stays out of it.
- Defend. Management gets involved, but Quality relies on rules, procedures, fear and discipline. New standards are created for protection rather than improvement.
- Master. Everyone knows the risks of their activity and cares about their own behaviour. Quality relies on people’s knowledge and values.
- Anticipate. Responsibility is collective. Everyone also looks out for their colleagues’ work, and product robustness becomes a source of team pride.
This last level matches the ambition the FDA is pursuing through the concept of Quality Management Maturity. It’s the direction regulation is taking.
Signs that don’t lie
A site that endures or defends can be recognised by a few symptoms:
- leadership believes it’s enough to follow procedures, while the shop floor knows those procedures no longer reflect the real activity;
- actions arising from deviations boil down to changing a procedure and “reminding people of the rules”;
- the only Quality indicator is the number of deviations;
- all the pressure of release rests on the Quality department, and nobody can give a reliable lead time;
- teams no longer really know what the medicines they make are for.
Why Lean or “right first time” isn’t enough
Many sites launch a Lean programme or set an ambitious right-first-time target without looking at the cultural foundation. The result is predictable: in a culture that endures, 95% right first time is impossible; in a culture that defends, it’s a dream. Only from the “Master” level does this target become achievable, and at the “Anticipate” level it becomes a choice. Tools amplify an existing culture. They don’t create it.
How to make a real diagnosis
A useful diagnosis isn’t made from an office. It combines three perspectives:
- Survey each population on the site, from leadership to operators, to understand how each perceives Quality. The gaps between populations are often the first lesson.
- Observe the shop floor through task observations, which reveal the gaps between work as prescribed and work as done.
- Look at weak signals: the small anomalies, irritants and near-deviations that nobody reports.
It’s from this diagnosis that you can choose the right levers: align leadership, make Quality more pragmatic, and make the shop floor proactive. And to get started, you can already ask yourself which quality professional profile you resemble.
